TRODELVY sacituzumab govitecan 180 mg powder for injection vial

Gilead Sciences Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: db1e71b2d8b75e29
Product Name: TRODELVY sacituzumab govitecan 180 mg powder for injection vial
Artg Id: 353081
Artg Name: TRODELVY sacituzumab govitecan 180 mg powder for injection vial
Sponsor: Gilead Sciences Pty Ltd
Company Detail Path: /organization/gilead-sciences-pty-limited
Artg Date: 2021-09-06
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/18aca39cb8cfa68a301fb2a5273d4bbd.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/faacb14b2c0a00b7fa0824679a3172b0.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

db1e71b2d8b75e29

Type

Standard